299 related articles for article (PubMed ID: 24379819)
21. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
[TBL] [Abstract][Full Text] [Related]
23. The ins and outs of MHC class II-mediated antigen processing and presentation.
Roche PA; Furuta K
Nat Rev Immunol; 2015 Apr; 15(4):203-16. PubMed ID: 25720354
[TBL] [Abstract][Full Text] [Related]
24. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.
Malnati MS; Marti M; LaVaute T; Jaraquemada D; Biddison W; DeMars R; Long EO
Nature; 1992 Jun; 357(6380):702-4. PubMed ID: 1614517
[TBL] [Abstract][Full Text] [Related]
25. A central role for HSC70 in regulating antigen trafficking and MHC class II presentation.
Deffit SN; Blum JS
Mol Immunol; 2015 Dec; 68(2 Pt A):85-8. PubMed ID: 25953005
[TBL] [Abstract][Full Text] [Related]
26. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
Becker HJ; Kondo E; Shimabukuro-Vornhagen A; Theurich S; von Bergwelt-Baildon MS
Eur J Haematol; 2016 Aug; 97(2):166-74. PubMed ID: 26561366
[TBL] [Abstract][Full Text] [Related]
27. Differing processing requirements of four recombinant antigens containing a single defined T-cell epitope for presentation by major histocompatibility complex class II.
Colledge L; Sun MY; Lin W; Blackburn CC; Reay PA
Immunology; 2001 Jul; 103(3):343-50. PubMed ID: 11454063
[TBL] [Abstract][Full Text] [Related]
28. Revisiting nonclassical HLA II functions in antigen presentation: Peptide editing and its modulation.
Álvaro-Benito M; Freund C
HLA; 2020 Oct; 96(4):415-429. PubMed ID: 32767512
[TBL] [Abstract][Full Text] [Related]
29. Capture and processing of exogenous antigens for presentation on MHC molecules.
Watts C
Annu Rev Immunol; 1997; 15():821-50. PubMed ID: 9143708
[TBL] [Abstract][Full Text] [Related]
30. Allergy to antibiotics: T-cell recognition of amoxicillin is HLA-DR restricted and does not require antigen processing.
Horton H; Weston SD; Hewitt CR
Allergy; 1998 Jan; 53(1):83-8. PubMed ID: 9491234
[TBL] [Abstract][Full Text] [Related]
31. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
[TBL] [Abstract][Full Text] [Related]
32. Functional evidence for TCR-intrinsic specificity for MHCII.
Parrish HL; Deshpande NR; Vasic J; Kuhns MS
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
[TBL] [Abstract][Full Text] [Related]
33. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.
Nag B; Deshpande SV; Sharma SD; Clark BR
J Biol Chem; 1993 Jul; 268(19):14360-6. PubMed ID: 7686154
[TBL] [Abstract][Full Text] [Related]
34. MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.
ten Broeke T; Wubbolts R; Stoorvogel W
Cold Spring Harb Perspect Biol; 2013 Dec; 5(12):a016873. PubMed ID: 24296169
[TBL] [Abstract][Full Text] [Related]
35. EpsinR, a target for pyrenocine B, role in endogenous MHC-II-restricted antigen presentation.
Shishido T; Hachisuka M; Ryuzaki K; Miura Y; Tanabe A; Tamura Y; Kusayanagi T; Takeuchi T; Kamisuki S; Sugawara F; Sahara H
Eur J Immunol; 2014 Nov; 44(11):3220-31. PubMed ID: 25196058
[TBL] [Abstract][Full Text] [Related]
36. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.
Rüssmann H; Panthel K; Köhn B; Jellbauer S; Winter SE; Garbom S; Wolf-Watz H; Hoffmann S; Grauling-Halama S; Geginat G
Infect Immun; 2010 Dec; 78(12):5138-50. PubMed ID: 20876292
[TBL] [Abstract][Full Text] [Related]
37. Autophagy and MHC-restricted antigen presentation.
Valečka J; Almeida CR; Su B; Pierre P; Gatti E
Mol Immunol; 2018 Jul; 99():163-170. PubMed ID: 29787980
[TBL] [Abstract][Full Text] [Related]
38. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins.
Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F
J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631
[TBL] [Abstract][Full Text] [Related]
39. Autophagy in MHC class II antigen processing.
Strawbridge AB; Blum JS
Curr Opin Immunol; 2007 Feb; 19(1):87-92. PubMed ID: 17129719
[TBL] [Abstract][Full Text] [Related]
40. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
